Latanoprostene Bunod

Overview

Latanoproste bunod is a nitric oxide-donating prostaglandin F2α (FP) receptor agonist. Under the trade name Vyzulta, it has been approved for the treatment of intraocular pressure in patients with open-angle glaucoma or ocular hypertension in 2017.

Application

Products > Drug Discovery > APIs > Generic APIs | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B2692-291720
• CAS No.: 860005-21-6
• Molecular Formula: C27H41NO8
• Molecular Weight: 507.62
• Purity: ≥95%

Source

Original product source